AMBICION
AMBICION develops new drugs focused on establishing a global standard treatment for cancer patients. The company's is called product Natural killer T cells or NKT cells, a type of T cells that also have NK cell properties. It is activated by recognizing glycolipid antigens, produce many types of cytokines, and induce both immunostimulation and suppression reactions. NKT cells can induce cell death to cancer cells due to the nature of NK cells, but its direct cytotoxic activity is limited due to the small amount present in the body. NKT cells also have the ability to produce large amounts of cytokines. AMBICION was founded in October 2015 and is headquartered in Tokyo, Japan.
AMBICION
Industry:
Biotechnology Health Care Medical Nursing And Residential Care Product Research Wellness
Founded:
2015-10-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.ambicion.co.jp
Total Employee:
1+
Status:
Active
Contact:
03-5357-7231
Email Addresses:
[email protected]
Total Funding:
6.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Mobile Non Scaleable Content Euro Pound Sterling Japanese Yen
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
GenoMembrane
GenoMembrane provides both SLC transporters and ABC transporter Vesicles/reagents for you to facilitate drug discovery
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Current Employees Featured
Investors List
Regional Health Care Industry Support Fund
Regional Health Care Industry Support Fund investment in Venture Round - AMBICION
Toho Holdings
Toho Holdings investment in Venture Round - AMBICION
REVIC
REVIC investment in Venture Round - AMBICION
REVIC
REVIC investment in Venture Round - AMBICION
Regional Health Care Industry Support Fund
Regional Health Care Industry Support Fund investment in Venture Round - AMBICION
Official Site Inspections
http://www.ambicion.co.jp
- Host name: 153.122.205.14
- IP address: 153.122.205.14
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "AMBICION"
Company Profile Company Profile - ambicion.co.jp
JP; EN; Company Profile Company Profile Company Profile Company name AMBICION Co., Ltd. Address Wako Bldg. 5F, 2-6 Samoncho, Shinjuku-ku, Tokyo Phone +81 3-5357-7231 FAX โฆSee details»
Ambicion
Delivering new value to cancer patients at an early stage Unlocking new potential In pursuit of original new drug creation solutionsSee details»
Company Profile ๏ฝ AMBICION
Technology Natural Killer T (NKT) Cells; NKT cell functions; Mechanisms of NKT cell-targeted cancer immunotherapy; Advantages of NKT cell-targeted cancer immunotherapySee details»
AMBICION - Crunchbase Company Profile & Funding
Organization. AMBICION . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number โฆSee details»
AMBICION CO., LTD. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AMBICION CO., LTD. of SHINJUKU-KU, TOKYO. Get the latest business insights from Dun & Bradstreet.See details»
Ambicion - Overview, News & Similar companies | ZoomInfo.com
View Ambicion (www.ambicion.co.jp) location in Tokyo, Japan , revenue, industry and description. Find related and similar companies as well as employees by title and much more. ...See details»
AMBICION | Company | Mindmaps
AMBICION develops new drugs focused on establishing a global standard treatment for cancer patients. Headquarters: Asia-Pacific (APAC) Industry: PharmTech. Employee Number: 1-10. โฆSee details»
Ambicion Company Profile 2024: Valuation, Funding & Investors
Ambicion General Information Description. Developer of cancer immunotherapy intended to contribute to society by providing cancer treatment to the world. The company's natural killer T โฆSee details»
AMBICION, LIMITED LIABILITY CO. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AMBICION, LIMITED LIABILITY CO. of SHIBUYA-KU, TOKYO. Get the latest business insights from Dun โฆSee details»
Ambicion - Products, Competitors, Financials, Employees, โฆ
Headquarters Location. Wako Building, 5th Floor 2-6 Samon-cho, Shinjuku-ku. Tokyo, 160-0017, Japan. 81 3 5357 7231See details»
Ambicion Co. Ltd. - BioCentury Company Profiles - BCIQ
Ambicion Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
AMBICION Co., Ltd. Asset Profile | Preqin
Established in 2015 and based in Tokyo, AMBICION Co., Ltd. is a biotechnology company focusing on research and development of new cancer immunotherapy target...See details»
Inquiries ๏ฝ AMBICION
AMBICION Co., Ltd. Company Profile. Company Profile ... Relationship between RIKEN and AMBICION; Clinical data on NKT cell-targeted cancer immunotherapy; Discovery of a novel โฆSee details»
AMBICION Reviews | Read Client Reviews of AMBICION.
Read reviews of AMBICION. Write and share your personal story. Your experience will help others make the right buying decision. Trustburn. ... Search. Be brave like Ukraine. AMBICION โฆSee details»
Company Profile Message from the CEO - ambicion.co.jp
Company Profile Message from the CEO . AMBICION is the Spanish word for โambitionโ. While Professor William S. Clarkโs words to Japanese students, โBoys, be ambitious!โ is a famous โฆSee details»
Ambicion Management Team - CB Insights
Explore {Ambicion's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Ambicion CEO, Founder, Key โฆSee details»
April 18, 2018 Corporate Norio Hamada, Chairman of the Board ...
Apr 18, 2018 Company Name TOHO HOLDINGS CO., LTD. Corporate Representative Norio Hamada, Chairman of the Board and Representative Director (First Section of Tokyo Stock โฆSee details»
Ambicion Stock Price, Funding, Valuation, Revenue & Financial โฆ
Apr 18, 2018 See Ambicion funding rounds, investors, investments, exits and more. Evaluate their financials based on Ambicion's post-money valuation and revenue. ... ambicion.co.jp. โฆSee details»
Company Profile Company Philosophy - ambicion.co.jp
Technology Natural Killer T (NKT) Cells; NKT cell functions; Mechanisms of NKT cell-targeted cancer immunotherapy; Advantages of NKT cell-targeted cancer immunotherapySee details»
Technology ๏ฝ AMBICION
Technology Natural Killer T (NKT) Cells; NKT cell functions; Mechanisms of NKT cell-targeted cancer immunotherapy; Advantages of NKT cell-targeted cancer immunotherapySee details»